Author | Rodrigo Cunha Guimarães, MD


Gemcitabine and Paclitaxel as Salvage Therapy in Metastatic Breast Cancer

February 01, 2001

ByAndre Marcio Murad, MD, PhD|Rodrigo Cunha Guimarães, MD|Bruno Cortes Aragão, MD|Antonio Orlando Scalabrini-neto, MD|Victor Hugo Rodrigues, MD|Renato Garcia

In a phase II trial, 29 patients with anthracycline-pretreated or anthracycline-resistant metastatic breast cancer in whom anthracycline-containing first- or second-line chemotherapy failed received combination paclitaxel